Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3029980 | Thrombosis Research | 2008 | 5 Pages |
Abstract
These results suggest that long-term rHuEPO therapy can correct fibrinolytic parameters in patients undergoing regular HD irrespective from haemoglobin levels and in the absence of concomitant iron supplementation.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Krystyna Pawlak, Dariusz Pawlak, Michal Mysliwiec,